South Africa approved lenacapavir on October 21, 2025—a twice-yearly injection offering near-100% HIV protection. This ...

GSK shares rose to the top of the FTSE 100 leader board after the drugmaker raised its 2025 guidance on the back of a strong third-quarter performance. The earnings were the last to be presented by ...

Shares in the company rose on Wednesday morning as a result, lifting to their highest level for more than a year.